suplatast tosilate has been researched along with Cystitis, Interstitial in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homma, Y; Ueda, T; Yoshimura, N | 1 |
Gotoh, S; Nagai, A; Nagaoka, M; Nakazawa, H; Tamaoki, J | 1 |
Nakamura, Y; Ogawa, H; Sakakura, N; Tokinaga, K; Yamashita, M | 1 |
Boucher, W; Cao, J; Kempuraj, D; Papaliodis, D; Theoharides, TC | 1 |
Hayashi, Y; Irimura, K; Kiniwa, M; Kirimoto, T; Matsuura, N; Nakano, K; Oka, T; Yoshimura, N | 1 |
Honma, Y; Ito, T; Takei, M; Ueda, T | 1 |
Ogawa, O; Tamaki, M; Ueda, T; Yamauchi, T; Yoshimura, N | 1 |
Bjerklund Johansen, TE; Weidner, W | 1 |
1 review(s) available for suplatast tosilate and Cystitis, Interstitial
Article | Year |
---|---|
Understanding chronic pelvic pain syndrome.
Topics: Arylsulfonates; Cystitis, Interstitial; Cytokines; Female; Histamine Antagonists; Humans; Male; Mast Cells; Neurogenic Inflammation; Pelvic Pain; Placebo Effect; Prostatitis; Sulfonium Compounds; Syndrome | 2002 |
2 trial(s) available for suplatast tosilate and Cystitis, Interstitial
Article | Year |
---|---|
Suplatast tosilate in patients with interstitial cystitis: Efficacy and treatment possibilities, with suggestions for future assessments.
Topics: Administration, Oral; Adult; Aged; Arylsulfonates; Cystitis, Interstitial; Cystoscopy; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Patient Selection; Placebo Effect; Severity of Illness Index; Sulfonium Compounds; Th2 Cells; Treatment Outcome; Urinary Bladder | 2019 |
Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Antigens, CD20; Arylsulfonates; Cystitis, Interstitial; Eosinophils; Female; Humans; Immunoglobulin E; Interleukin-4; Interleukin-5; Leukocyte Common Antigens; Leukocyte Count; Sulfonium Compounds; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer | 2000 |
5 other study(ies) available for suplatast tosilate and Cystitis, Interstitial
Article | Year |
---|---|
[A case of Sjögren syndrome accompanied by interstitial cystitis and interstitial pneumonia improved by suplatast tosilate and prednisolone].
Topics: Aged; Arylsulfonates; Cystitis, Interstitial; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Prednisolone; Sjogren's Syndrome; Sulfonium Compounds | 2003 |
[Case of interstitial cystitis accompanied by food allergy].
Topics: Anti-Allergic Agents; Arylsulfonates; Cetirizine; Cystitis, Interstitial; Cystoscopy; Drug Therapy, Combination; Female; Food Hypersensitivity; Histamine H1 Antagonists, Non-Sedating; Humans; Middle Aged; Sulfonium Compounds | 2005 |
Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
Topics: Administration, Intravesical; Animals; Arylsulfonates; Capillary Permeability; Cell Culture Techniques; Cystitis, Interstitial; Female; Histamine Antagonists; Histamine Release; Humans; Male; Mast Cells; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Skin; Sulfonium Compounds; Tumor Necrosis Factor-alpha | 2007 |
Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Cystitis, Interstitial; Disease Models, Animal; Female; Rats; Rats, Sprague-Dawley; Sulfonium Compounds; T-Lymphocytes; Treatment Outcome | 2007 |
Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Allergic Agents; Anti-Bacterial Agents; Arylsulfonates; Asian People; Cystitis, Interstitial; Female; Humans; Male; Medical History Taking; Middle Aged; Sex Distribution; Sulfonium Compounds | 2007 |